Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03520790
Recruitment Status : Recruiting
First Posted : May 11, 2018
Last Update Posted : September 23, 2019
Sponsor:
Collaborators:
Stand Up To Cancer
Lustgarten Foundation
American Association for Cancer Research
Information provided by (Responsible Party):
Kimberly Perez, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 30, 2021
Estimated Study Completion Date : November 30, 2025